Two Seas Capital LP’s Arbutus Biopharma Corp Position
Does Two Seas Capital LP own Arbutus Biopharma Corp (I9DN)? Yes — 18.56M shares worth $84M (+1.17% of its 13F portfolio) as of Q1 2026, up from 12.59M shares the prior filed quarter.
Position Value
$84M
Q1 2026
Shares
18.56M
% of Portfolio
+1.17%
Quarters Held
18
currently held
Position History I9DN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 18.56M | $84M | +1.17% |
| Q4 2025 | 12.59M | $61M | +1.25% |
| Q3 2025 | 10.99M | $50M | +0.80% |
| Q2 2025 | 10.44M | $32M | +0.54% |
| Q1 2025 | 9.47M | $33M | +1.04% |
| Q4 2024 | 8.74M | $29M | +2.47% |
| Q3 2024 | 8.39M | $32M | +5.23% |
| Q2 2024 | 8.57M | $26M | +4.30% |
| Q1 2024 | 7.84M | $20M | +3.96% |
| Q4 2023 | 9.04M | $23M | +5.52% |
| Q3 2023 | 8.28M | $17M | +3.38% |
| Q2 2023 | 8.28M | $19M | +4.16% |
| Q1 2023 | 7.46M | $23M | +20.76% |
| Q4 2022 | 7.50M | $17M | +16.61% |
| Q3 2022 | 5.65M | $11M | +9.86% |
| Q2 2022 | 3.50M | $9M | +12.35% |
| Q1 2022 | 2.20M | $7M | +5.49% |
| Q4 2021 | 825.6K | $3M | +2.46% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Two Seas Capital LP’s full portfolio or all institutional holders of I9DN.